Results 201 to 210 of about 228,142 (338)

Distinct patterns of ventricular fibrillation onset in primary electrical diseases: insights from a retrospective multicentre registry. [PDF]

Europace
Surget E, Wences Mansogo W, Porretta AP, Beyler C, Bloch A, Denjoy I, Haissaguerre M, Extramiana F.   +7 more
europepmc   +1 more source

Increased Susceptibility of the Heart to Ventricular Fibrillation During Metabolic Acidosis

, 1966
Paul H. Gerst, William H. Fleming, James R. Malm   +2 more
openalex   +1 more source

Predictors of ventricular fibrillation or cardiac arrest in patients hospitalized for acute myocardial infarction [PDF]

, 1981
James Tonascia, Moysés Szklo, Robert J. Goldberg, Harold L. Kennedy   +3 more
openalex   +1 more source

Early in‐hospital treatment of acute heart failure. Part 2 of the international expert opinion series on AHF management

ESC Heart Failure, EarlyView.
This state‐of‐the‐art review outlines a practical, evidence‐based framework for early acute heart failure management to address critical gaps in current guidance and improve early treatment outcomes. Key components include early identification of co‐existing conditions, bedside haemodynamic profiling, a structured diagnostic approach incorporating both
Anika S. Naidu, Andrew P. Ambrosy, Gad Cotter, Edimar A. Bocchi, Javed Butler, Ovidiu Chioncel, Beth Davison, Anastase Dzudie, Yonathan Freund, Marat Fudim, Sivadasanpillai Harikrishnan, Ivna G. Cunha, Alexandre Mebazaa, Robert J. Mentz, Òscar Miró, Siti E. Nauli, Mateo Pagnesi, Naoki Sato, Gianluigi Savarese, Karen Sliwa‐Hahnle, Yuhui Zhang, Jingmin Zhou, Jan Biegus   +22 more
wiley   +1 more source

Accelerated Ischemic Disease Presenting as Ventricular Fibrillation. [PDF]

J Community Hosp Intern Med Perspect
Javed N, Itare V, Ali N, Krim N, Jadhav P.   +4 more
europepmc   +1 more source

Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT‐MI

ESC Heart Failure, EarlyView.
Impact of empagliflozin in patients with and without T2D or CKD in the EMPACT‐MI trial. Baseline characteristics, HF outcomes and subgroup analysis of efficacy endpoints are shown. # Hazard ratios estimated via Cox proportional hazard model (unless indicated otherwise). ^ Rate ratios via negative binomial regression.
Francesco Fioretti, Javed Butler, Jacob A. Udell, W. Schuyler Jones, Mark C. Petrie, Josephine Harrington, Michaela Mattheus, Johann Bauersachs, Antoni Bayes‐Genis, Shaun G. Goodman, Tomasz Gasior, James L. Januzzi, Renato D. Lopes, Piotr Ponikowski, Xavier Rossello, Morten Schou, Peter van der Meer, Dragos Vinereanu, Shelley Zieroth, Martina Brueckmann, Mikhail Sumin, Deepak L. Bhatt, Adrian F. Hernandez, Stefan D. Anker   +23 more
wiley   +1 more source

Fulminant Myocarditis Presenting With Refractory Ventricular Fibrillation During BRAF/MEK Inhibitor Therapy. [PDF]

JACC Case Rep
Lalario A, Rubbo FM, Bassetto G, Mazzaro E, Pinamonti M, Bussani R, Sinagra G, Stolfo D.   +7 more
europepmc   +1 more source

Structure of ventricular systole in patients with atherosclerotic cardiosclerosis complicated by atrial fibrillation

, 1969
L. I. Uzbekova
openalex   +2 more sources

Predicting acute decompensated heart failure using circadian markers from heart rate time series

ESC Heart Failure, EarlyView.
Circadian metrics—amplitude, mesor, and acrophase—derived from a wrist‐worn heart rate monitor can predict acute decompensated heart failure (ADHF) up to 21 days before onset. In 65 post‐ADHF patients, an LSTM model achieved 74% sensitivity, and 73% specificity trained on 21‐day sequences. These findings support circadian rhythm analysis as a promising
Valerie A. A. van Es, Mayke M. C. J. van Leunen, Ignace L. J. de Lathauwer, Cindy C. A. G. Verstappen, René A. Tio, Ruud F. Spee, Lu Yuan, Monica Betta, Giacomo Handjaras, Hareld M. C. Kemps   +9 more
wiley   +1 more source

Unexpected ventricular fibrillation triggered by pulsed field ablation for atrial fibrillation. [PDF]

HeartRhythm Case Rep
Zaher W, Combes N, Boveda S, Albenque JP, Cardin C, Combes S, Voglimacci-Stephanopoli Q.   +6 more
europepmc   +1 more source